Entera Bio Income Statement (2017-2025) | ENTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	0.16M	0.11M	0.14M	0.17M	0.07M	0.04M	0.01M	0.01M						0.06M	0.04M	0.08M	0.04M
Cost of Revenue (Quarter)	0.07M	0.10M	0.07M	0.14M	0.05M	0.03M	0.01M	0.01M						0.05M	0.04M	0.08M	0.04M
Gross Profit (Quarter)	0.08M	0.01M	0.07M	0.03M	0.01M	0.01M	0.00M	0.01M						0.01M
Operating items
Research & Development (Quarter)	1.12M	1.23M	1.77M	2.65M	1.69M	1.39M	1.41M	1.35M	0.93M	1.21M	1.37M	1.00M	0.73M	1.09M	1.48M	1.20M	1.12M	1.52M	1.64M	1.72M
Share-based Compensation (IS) (Quarter)	0.33M	0.62M	0.54M
Selling, General & Administrative (Quarter)	1.31M	1.36M	1.53M	1.48M	2.17M	1.88M	1.46M	1.74M	1.29M	1.14M	1.03M	0.97M	1.33M	1.09M	1.54M	1.14M	1.44M	1.15M	1.61M	1.32M
Other Operating Expenses (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.01M	0.01M
Operating Expenses (Quarter)	2.42M	2.58M	3.29M	4.12M	3.85M	3.26M	2.87M	3.07M	2.21M	2.33M	2.39M	1.96M	2.06M	2.17M	3.02M	2.34M	2.56M	2.67M	3.26M	3.04M
Operating Income (Quarter)	-2.34M	-2.57M	-3.22M	-4.09M	-3.83M	-3.25M	-2.87M	-3.07M	-2.21M	-2.33M	-2.39M	-1.96M	-2.06M	-2.17M	-3.02M	-2.34M	-2.56M	-2.67M	-3.26M	-3.03M
EBIT (Quarter)	-2.34M	-2.57M	-3.22M	-4.09M	-3.83M	-3.25M	-2.87M	-3.07M	-2.21M	-2.33M	-2.39M	-1.96M	-2.06M	-2.17M	-3.02M	-2.34M	-2.56M	-2.67M	-3.26M	-3.03M
Non-operating items
Interest & Investment Income (Quarter)			-0.68M
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)	-0.01M	-0.02M	-0.01M	-0.03M	0.04M	0.06M	-0.01M	-0.01M	0.02M	0.01M	0.04M	-0.03M	0.04M	0.02M		-0.01M	-0.00M	0.01M	0.06M	0.03M
Net income details
EBT (Quarter)	-2.31M	-2.59M	-3.23M	-4.12M	-3.79M	-3.19M	-2.87M	-3.08M	-2.19M	-2.33M	-2.35M	-2.00M	-2.06M	-2.17M	-3.02M	-2.34M	-2.56M	-2.67M	-3.26M	-3.03M
Tax Provisions (Quarter)	-0.01M	-0.02M	-0.01M	-0.01M	-0.01M	-0.00M	0.19M	-0.05M			0.03M					0.01M
Profit After Tax (Quarter)	-9.49M	-2.58M	-3.21M	-4.10M	-3.78M	-3.19M	-3.07M	-3.04M	-2.19M	-2.33M	-2.38M	-2.00M	-2.02M	-2.15M	-3.02M	-2.36M	-2.57M	-2.66M	-3.20M	-3.02M
Income from Continuing Operations (Quarter)	-2.30M	-2.58M	-3.21M	-4.10M	-3.78M	-3.19M	-3.07M	-3.04M	-2.19M	-2.33M	-2.38M	-2.00M	-2.06M	-2.17M	-3.02M	-2.36M	-2.56M	-2.67M	-3.26M	-3.03M
Consolidated Net Income (Quarter)	-2.30M	-2.58M	-3.21M	-4.10M	-3.78M	-3.19M	-3.07M	-3.04M	-2.19M	-2.33M	-2.38M	-2.00M	-2.06M	-2.17M	-3.02M	-2.36M	-2.56M	-2.67M	-3.26M	-3.03M
Income towards Parent Company (Quarter)	-2.30M	-2.58M	-3.21M	-4.10M	-3.78M	-3.19M	-3.07M	-3.04M	-2.19M	-2.33M	-2.38M	-2.00M	-2.06M	-2.17M	-3.02M	-2.36M	-2.56M	-2.67M	-3.26M	-3.03M
Net Income towards Common Stockholders (Quarter)	-2.30M	-2.58M	-3.21M	-4.10M	-3.78M	-3.19M	-3.07M	-3.04M	-2.19M	-2.33M	-2.38M	-2.00M	-2.06M	-2.17M	-3.02M	-2.36M	-2.56M	-2.67M	-3.26M	-3.03M
Additional items
EPS (Basic) (Quarter)	0.10	0.11	0.11	0.15	0.13	0.11	0.11	0.10	0.08	0.08	0.08	0.07	0.05	0.06	0.08	0.06	0.06	0.06	0.07	0.07
EPS (Weighted Average and Diluted) (Quarter)		-0.11	0.11	0.15	0.13	0.11	0.11	0.10	0.08	0.08	0.08	0.07	0.05	0.06	0.08	0.06	0.06	0.06	0.07	0.07
Shares Outstanding (Weighted Average) (Quarter)	21.89M	24.72M	28.68M	26.13M	28.80M	28.81M	28.81M	28.81M	28.81M	28.81M	28.81M	29.01M	36.74M	37.09M	37.16M	37.65M	43.38M	45.15M	47.09M	46.19M
Shares Outstanding (Diluted Average) (Quarter)		23.38M	28.68M	26.13M	28.80M	28.81M	28.81M	28.81M	28.81M	28.81M	28.81M	29.01M	36.74M	36.91M	37.16M	37.65M	43.38M	46.84M	47.09M	46.19M
EBITDA (Quarter)	9.49M	5.15M	2.46M	-4.09M	-3.83M	-3.25M	-2.87M	-3.07M	-2.21M	-2.33M	-2.39M	-1.96M	-2.06M	-2.17M	-3.02M	-2.34M	-2.56M	-2.67M	-3.26M	-3.03M
Interest Expenses (Quarter)	7.09M	2.46M	-0.68M
Tax Rate (Quarter)	0.61%	0.66%	0.40%	0.36%	0.18%	0.13%	-6.75%	1.49%			-1.23%					-0.60%

Research Tools

Entera Bio Income Statement (2017-2025) | ENTX

Create an account

Sign In

Reset Password